Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-01

Clinical Trial Update: Safety, Tolerability, Kinetics and Efficacy Study of Hoodia Gordonii Purified Extract (PYM50717) [NA]

View source ↗

Summary

This completed trial assessed safety, tolerability, pharmacokinetics and efficacy of Hoodia Gordonii purified extract (PYM50717) for appetite suppression and we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hoodia Gordonii Purified Extract (PYM50717) (Hoodia Gordonii purified extract)

Snippet

Sponsor: Unilever R&D | Conditions: Appetite Depressant, Overweight | NA | Status: COMPLETED